美容注射市場：製品、性別、用途、エンドユーザー別-2025-2030年の世界予測

美容注射市場は、2023年に110億8,000万米ドルと評価され、2024年には119億5,000万米ドルに達すると予測され、CAGR 7.85％で成長し、2030年には188億1,000万米ドルになると予測されています。

美容注射は、皮膚充填剤とボツリヌス毒素を包含し、若々しい外観を取り戻し、顔の特徴を強化することを目的としています。これらの製品は、しわの減少、唇の増大、顔の輪郭形成など、様々な美容上の悩みに対応します。非外科的で低侵襲な美容治療への要望の高まりは、製品処方の進歩や美的改善を求める高齢化人口の増加に後押しされ、美容注射の必要性を強調しています。用途としては、額、カラスの足跡、頬、唇、顎のラインなどの顔面領域に投与することができます。主なエンドユーザーは、美容クリニック、皮膚科センター、病院、時には歯科診療所などです。市場促進要因としては、可処分所得の増加、ソーシャルメディアの影響による美容動向の増幅、美容治療に対する意識の高まりなどが挙げられます。さらに、男性消費者の関心も高まっており、市場はさらに拡大しています。しかし、潜在的な副作用、特定の地域における訓練された専門家の不足、割高な治療費などの制約があります。さらに、厳しい規制の枠組みは、特に製品承認と安全性コンプライアンスに関して、市場成長に大きな課題を突きつけています。潜在的な機会を活用するために、企業は、治療用途を包含するように製品の適応を拡大するとともに、耐久性の向上と模倣性の強化を保証する製品配合の革新に注力すべきです。生分解性代替品や個別化注射剤の調査は、標的を絞った美容療法の新時代を切り開く可能性があります。さらに、化粧品支出が増加している新興市場での地理的プレゼンスを拡大することで、新たなビジネスの道が開ける可能性があります。技術革新の面では、AIを活用したカウンセリングにより、患者一人ひとりに合わせた治療計画が可能になり、患者の満足度が向上する可能性があります。市場力学はダイナミックであり、主に消費者心理と新たな美容基準に左右されるため、競争優位性を維持するためには継続的な適応とイノベーションが必要となります。企業は、市場機会を効果的に活用するために、技術の進歩や規制の変更に後れを取らないようにする必要があります。

市場力学：急速に進化する美容注射市場の主要市場インサイトを公開

美容注射市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 美容動向と高齢化に伴う美容注射の利用増
  • スパや美容サロンの増加
  • 美容治療の選択肢を促進する政府や保健当局の改革
• 市場抑制要因
  • 美容注射の高コストと製品リコール
• 市場機会
  • 美容注射を投与するためのツールや方法における継続的な技術革新
  • 美容注射の新興企業へのベンチャーキャピタル投資
• 市場の課題
  • 美容注射に伴う健康リスク

ポーターのファイブフォース：美容注射市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、美容注射市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：美容注射市場における外部からの影響の把握

外部マクロ環境要因は、美容注射市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析美容注射市場における競合情勢の把握

美容注射市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス美容注射市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、美容注射市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨美容注射市場における成功への道筋を描く

美容注射市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 美容動向と人口の高齢化により美容注射の利用が増加
    • スパや美容サロンの増加
    • 美容治療の選択肢を促進する政府と保健当局の改革
  • 抑制要因
    • 美容注射と製品リコールのコストが高い
  • 機会
    • 美容注射の管理に使用されるツールと方法の継続的な革新
    • 美容注射の新興企業へのベンチャーキャピタル投資
  • 課題
    • 美容注射に関連する健康リスク
• 市場セグメンテーション分析
  • タイプ：しわを減らすためのアンチエイジング注射の使用増加
  • エンドユーザー：皮膚科クリニックではさまざまな美容治療を提供しているため、美容注射へのアクセス性が高い
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 美容注射市場：製品別

• アンチエイジング注射
  • ボツリヌス毒素A
  • ポリ-L-乳酸（PLLA）微粒子
• 皮膚充填剤
  • コラーゲンフィラー
  • ヒアルロン酸
  • 合成充填剤

第7章 美容注射市場性別

• 女性
• 男

第8章 美容注射市場：用途別

• ニキビ跡の治療
• フェイスリフト
• フェイスライン矯正
• 唇の増大
• 脂肪萎縮症の治療

第9章 美容注射市場：エンドユーザー別

• 美容クリニック
• 皮膚科クリニック
• 皮膚科学調査機関
• メディカルスパ

第10章 南北アメリカの美容注射市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の美容注射市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの美容注射市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • CynosureとLutronicが合併し、医療美容技術の世界的リーダーに
  • ガルデルマ、注射治療の結果を視覚化する新しいARツール「FACE by Galderma」を発表
  • FDA、頬を滑らかにする米国の新ヒアルロン酸注射剤「SKINVIVE by JUVEDERM」を承認
• 戦略分析と提言

企業一覧

• Adoderm GmbH
• Allergan, Inc. by AbbVie Inc.
• Anika Therapeutics, Inc.
• Bio Plus Co., Ltd.
• Bioxis Pharmaceuticals
• Bloomage Biotechnology Corp., Ltd.
• Bohus Biotech AB
• Croma-Pharma GmbH
• Cutera, Inc.
• Cynosure, LLC
• Dr. Korman Laboratories Ltd.
• Galderma SA
• Hugel America, Inc.
• Ipsen Pharma
• Laboratoires Vivacy, S.A.S.
• MedyTox Inc.
• Merz Pharma GmbH & Co.KGaA
• Prollenium Medical Technologies Inc.
• Revance Therapeutics, Inc.
• SciVision Biotech Inc.
• Sinclair Pharma Ltd
• Suneva Medical, Inc.
• Teoxane SA
• USWM, LLC
• Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. AESTHETIC INJECTABLES MARKET RESEARCH PROCESS
• FIGURE 2. AESTHETIC INJECTABLES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. AESTHETIC INJECTABLES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. AESTHETIC INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. AESTHETIC INJECTABLES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. AESTHETIC INJECTABLES MARKET DYNAMICS
• TABLE 7. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY ACNE SCAR TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FACE LIFT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY LIP AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY LIPOATROPHY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MEDICAL SPA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 52. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 53. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 54. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 84. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 85. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 86. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 90. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 91. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 92. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 193. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 194. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 195. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 215. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 216. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 217. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 218. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 219. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 221. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 223. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 224. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 225. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 281. AESTHETIC INJECTABLES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 282. AESTHETIC INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2023

The Aesthetic Injectables Market was valued at USD 11.08 billion in 2023, expected to reach USD 11.95 billion in 2024, and is projected to grow at a CAGR of 7.85%, to USD 18.81 billion by 2030.

Aesthetic injectables, encompassing dermal fillers and botulinum toxins, aim to restore a youthful appearance and enhance facial features. These products address various aesthetic concerns, including wrinkle reduction, lip augmentation, and facial contouring. The growing desire for non-surgical and minimally invasive cosmetic treatments, fueled by advancements in product formulations and an increasing aging population seeking aesthetic improvements, underscores the necessity for aesthetic injectables. Application-wise, these can be administered to facial areas like the forehead, crow's feet, cheeks, lips, and jawline. The primary end-users include cosmetic clinics, dermatology centers, hospitals, and at times, dental practices. Market insights reveal key growth drivers such as rising disposable incomes, social media influence amplifying beauty trends, and heightened awareness of aesthetic treatment availability. Additionally, male consumer interest is growing, further expanding the market. However, limitations include potential side effects, a lack of trained professionals in certain regions, and the premium cost of treatments. Moreover, stringent regulatory frameworks pose significant challenges to market growth, especially regarding product approval and safety compliance. To leverage potential opportunities, companies should focus on innovation in product formulations ensuring enhanced durability and mimetic enhancement, alongside expanding product indications to encompass therapeutic uses. Research into biodegradable alternatives and personalized injectables could usher in a new era of targeted cosmetic therapies. Additionally, expanding geographic presence in emerging markets with increasing cosmetic spending could provide new business avenues. On the innovation front, AI-driven consultations can allow for personalized treatment plans, improving patient satisfaction. The aesthetic injectables market is dynamic and primarily driven by consumer sentiments and emerging beauty standards, necessitating continuous adaptation and innovation to maintain competitive advantage. Businesses should stay abreast of technological advances and regulatory changes to effectively capitalize on market opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aesthetic Injectables Market

The Aesthetic Injectables Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising usage of aesthetic injections due to beauty trends and aging population
  • Increasing number of spa and beauty salons
  • Government and health authority reforms that promote aesthetic treatment options
• Market Restraints
  • High cost of aesthetic injectables and product recalls
• Market Opportunities
  • Ongoing innovations in the tools and methods used for administering aesthetic injectables
  • Venture capital investments into aesthetic injectable start-ups
• Market Challenges
  • Health risks associated with aesthetic injectables

Porter's Five Forces: A Strategic Tool for Navigating the Aesthetic Injectables Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aesthetic Injectables Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aesthetic Injectables Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aesthetic Injectables Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aesthetic Injectables Market

A detailed market share analysis in the Aesthetic Injectables Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aesthetic Injectables Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aesthetic Injectables Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aesthetic Injectables Market

A strategic analysis of the Aesthetic Injectables Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aesthetic Injectables Market, highlighting leading vendors and their innovative profiles. These include Adoderm GmbH, Allergan, Inc. by AbbVie Inc., Anika Therapeutics, Inc., Bio Plus Co., Ltd., Bioxis Pharmaceuticals, Bloomage Biotechnology Corp., Ltd., Bohus Biotech AB, Croma-Pharma GmbH, Cutera, Inc., Cynosure, LLC, Dr. Korman Laboratories Ltd., Galderma SA, Hugel America, Inc., Ipsen Pharma, Laboratoires Vivacy, S.A.S., MedyTox Inc., Merz Pharma GmbH & Co.KGaA, Prollenium Medical Technologies Inc., Revance Therapeutics, Inc., SciVision Biotech Inc., Sinclair Pharma Ltd, Suneva Medical, Inc., Teoxane SA, USWM, LLC, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Aesthetic Injectables Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Anti-aging Injections and Dermal Fillers. The Anti-aging Injections is further studied across Botulinum Toxin A and Poly-L-Lactic Acid (PLLA) Micro Particles. The Dermal Fillers is further studied across Collagen Fillers, Hyaluronic Acid, and Synthetic Fillers.
• Based on Gender, market is studied across Female and Male.
• Based on Application, market is studied across Acne Scar Treatment, Face Lift, Facial Line Correction, Lip Augmentation, and Lipoatrophy Treatment.
• Based on End User, market is studied across Beauty Clinics, Dermatology Clinics, Dermatology Research Institutes, and Medical Spa.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising usage of aesthetic injections due to beauty trends and aging population
    • 5.1.1.2. Increasing number of spa and beauty salons
    • 5.1.1.3. Government and health authority reforms that promote aesthetic treatment options
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of aesthetic injectables and product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing innovations in the tools and methods used for administering aesthetic injectables
    • 5.1.3.2. Venture capital investments into aesthetic injectable start-ups
  • 5.1.4. Challenges
    • 5.1.4.1. Health risks associated with aesthetic injectables
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Growing usage of anti-aging injections to reduce the appearance of wrinkles
  • 5.2.2. End User: High accessibility of aesthetic injectables by dermatology clinics as they provide several cosmetic treatments
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Aesthetic Injectables Market, by Product

• 6.1. Introduction
• 6.2. Anti-aging Injections
  • 6.2.1. Botulinum Toxin A
  • 6.2.2. Poly-L-Lactic Acid (PLLA) Micro Particles
• 6.3. Dermal Fillers
  • 6.3.1. Collagen Fillers
  • 6.3.2. Hyaluronic Acid
  • 6.3.3. Synthetic Fillers

7. Aesthetic Injectables Market, by Gender

• 7.1. Introduction
• 7.2. Female
• 7.3. Male

8. Aesthetic Injectables Market, by Application

• 8.1. Introduction
• 8.2. Acne Scar Treatment
• 8.3. Face Lift
• 8.4. Facial Line Correction
• 8.5. Lip Augmentation
• 8.6. Lipoatrophy Treatment

9. Aesthetic Injectables Market, by End User

• 9.1. Introduction
• 9.2. Beauty Clinics
• 9.3. Dermatology Clinics
• 9.4. Dermatology Research Institutes
• 9.5. Medical Spa

10. Americas Aesthetic Injectables Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Aesthetic Injectables Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Aesthetic Injectables Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Cynosure and Lutronic Merge to Form Global Leader in Medical Aesthetic Technology
  • 13.3.2. Galderma Launches FACE by Galderma, a New AR Tool Helps Visualize Injectable Treatment Results
  • 13.3.3. FDA Approves SKINVIVE by JUVEDERM, a new U.S. Hyaluronic Acid Injection for Smoother Cheeks
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Adoderm GmbH
• 2. Allergan, Inc. by AbbVie Inc.
• 3. Anika Therapeutics, Inc.
• 4. Bio Plus Co., Ltd.
• 5. Bioxis Pharmaceuticals
• 6. Bloomage Biotechnology Corp., Ltd.
• 7. Bohus Biotech AB
• 8. Croma-Pharma GmbH
• 9. Cutera, Inc.
• 10. Cynosure, LLC
• 11. Dr. Korman Laboratories Ltd.
• 12. Galderma SA
• 13. Hugel America, Inc.
• 14. Ipsen Pharma
• 15. Laboratoires Vivacy, S.A.S.
• 16. MedyTox Inc.
• 17. Merz Pharma GmbH & Co.KGaA
• 18. Prollenium Medical Technologies Inc.
• 19. Revance Therapeutics, Inc.
• 20. SciVision Biotech Inc.
• 21. Sinclair Pharma Ltd
• 22. Suneva Medical, Inc.
• 23. Teoxane SA
• 24. USWM, LLC
• 25. Zimmer Biomet Holdings, Inc.